Patel Snehal

Executive buyer

Director, CEO and CFO, 10% Owner · Greenwich LifeSciences, Inc.

Every open-market stock purchase Patel Snehal has reported to the SEC on Form 4 that met our signal bar, parsed straight from the filings. This page tracks where those buys landed inside insider clusters and how the prices paid compare to where the stock trades now.

Total bought

$2.6M

Open-market buys

Companies

Last buy

Jul 29, 2026

Where the buys stand today

GLSI
Greenwich LifeSciences, Inc.
6 purchases totalling $2.6M at an average of $14.26 per share. See all insider buying in GLSI →
Avg price paid
$14.26
Latest price
—
Market cap
Unknown

Cluster participation

Qualifying buys grouped with other insiders buying the same stock — the pattern this site exists to catch.

GLSIApr 1, 2024 – Apr 25, 2025
3 insiders$3.1M

All reported buys

Date	Ticker	Shares	Price	Value	Filing
Jul 29, 2026	GLSI	700	$13.10	$9.2K	SEC ↗
Jul 28, 2026	GLSI	1,500	$13.59	$20.4K	SEC ↗
Jul 27, 2026	GLSI	1,500	$13.62	$20.4K	SEC ↗
Jul 24, 2026	GLSI	1,100	$12.88	$14.2K	SEC ↗
Jul 23, 2026	GLSI	2,500	$13.14	$32.9K	SEC ↗
Jun 13, 2024	GLSIcluster	174,825	$14.30	$2.5M	SEC ↗

Follow new qualifying clusters involving Patel Snehal or other insiders

Explore qualifying clusters from public SEC filings. Pro adds email and Telegram notifications after detection.

Start a trial See pricing

About this data

Figures are parsed from Patel Snehal's Form 4 filings on SEC EDGAR (CIK 1806920) and cover open-market purchases (transaction code P) — grants, option exercises, and sales are excluded, which is why totals here can differ from raw filing counts. Every row links to its source document.

This page is informational and reflects public filing data. It is not investment advice.